Literature DB >> 26058841

More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.

Samantha L Rosenthal1, Mikhil N Bamne1, Xingbin Wang1, Sarah Berman2, Beth E Snitz2, William E Klunk3, Robert A Sweet4, F Yesim Demirci1, Oscar L Lopez2, M Ilyas Kamboh5.   

Abstract

Over 20 risk loci have been identified for late-onset Alzheimer's disease (LOAD), most of which display relatively small effect sizes. Recently, a rare missense (R47H) variant, rs75932628 in TREM2, has been shown to mediate LOAD risk substantially in Icelandic and Caucasian populations. Here, we present more evidence for the association of the R47H with LOAD risk in a Caucasian population comprising 4567 LOAD cases and controls. Our results show that carriers of the R47H variant have a significantly increased risk for LOAD (odds ratio = 7.40, p = 3.66E-06). In addition to Alzheimer's disease risk, we also examined the association of R47H with Alzheimer's disease-related phenotypes, including age-at-onset, psychosis, and amyloid deposition but found no significant association. Our results corroborate those of other studies implicating TREM2 as an LOAD risk locus and indicate the need to determine its biological role in the context of neurodegeneration.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LOAD; Rare variants; TREM2

Mesh:

Substances:

Year:  2015        PMID: 26058841      PMCID: PMC4465085          DOI: 10.1016/j.neurobiolaging.2015.04.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene.

Authors:  D Soragna; L Papi; M T Ratti; R Sestini; R Tupler; L Montalbetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

2.  Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.

Authors:  Robert A Sweet; David A Bennett; Neill R Graff-Radford; Richard Mayeux
Journal:  Brain       Date:  2010-02-10       Impact factor: 13.501

3.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

4.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

5.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

6.  The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  P N Tariot; J L Mack; M B Patterson; S D Edland; M F Weiner; G Fillenbaum; L Blazina; L Teri; E Rubin; J A Mortimer
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

7.  Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Authors:  Patricia A Wilkosz; Chowdari Kodavali; Elise A Weamer; Sachiko Miyahara; Oscar L Lopez; Vishwajit L Nimgaonkar; Steven T DeKosky; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

8.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia.

Authors:  Christine L Hsieh; Maya Koike; Steve C Spusta; Erene C Niemi; Midori Yenari; Mary C Nakamura; William E Seaman
Journal:  J Neurochem       Date:  2009-03-19       Impact factor: 5.372

9.  Genome-wide analysis of genetic loci associated with Alzheimer disease.

Authors:  Sudha Seshadri; Annette L Fitzpatrick; M Arfan Ikram; Anita L DeStefano; Vilmundur Gudnason; Merce Boada; Joshua C Bis; Albert V Smith; Minerva M Carassquillo; Jean Charles Lambert; Denise Harold; Elisabeth M C Schrijvers; Reposo Ramirez-Lorca; Stephanie Debette; W T Longstreth; A Cecile J W Janssens; V Shane Pankratz; Jean François Dartigues; Paul Hollingworth; Thor Aspelund; Isabel Hernandez; Alexa Beiser; Lewis H Kuller; Peter J Koudstaal; Dennis W Dickson; Christophe Tzourio; Richard Abraham; Carmen Antunez; Yangchun Du; Jerome I Rotter; Yurii S Aulchenko; Tamara B Harris; Ronald C Petersen; Claudine Berr; Michael J Owen; Jesus Lopez-Arrieta; Badri N Varadarajan; James T Becker; Fernando Rivadeneira; Michael A Nalls; Neill R Graff-Radford; Dominique Campion; Sanford Auerbach; Kenneth Rice; Albert Hofman; Palmi V Jonsson; Helena Schmidt; Mark Lathrop; Thomas H Mosley; Rhoda Au; Bruce M Psaty; Andre G Uitterlinden; Lindsay A Farrer; Thomas Lumley; Agustin Ruiz; Julie Williams; Philippe Amouyel; Steve G Younkin; Philip A Wolf; Lenore J Launer; Oscar L Lopez; Cornelia M van Duijn; Monique M B Breteler
Journal:  JAMA       Date:  2010-05-12       Impact factor: 56.272

10.  Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.

Authors:  Paul Hollingworth; Marian L Hamshere; Valentina Moskvina; Kimberley Dowzell; Pamela J Moore; Catherine Foy; Nicola Archer; Aoibhinn Lynch; Simon Lovestone; Carol Brayne; David C Rubinsztein; Brian Lawlor; Mike Gill; Michael J Owen; Julie Williams
Journal:  J Am Geriatr Soc       Date:  2006-09       Impact factor: 5.562

View more
  20 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

2.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 3.  Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging.

Authors:  Carlo Condello; Peng Yuan; Jaime Grutzendler
Journal:  Biol Psychiatry       Date:  2017-10-14       Impact factor: 13.382

4.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Authors:  Yuka Atagi; Chia-Chen Liu; Meghan M Painter; Xiao-Fen Chen; Christophe Verbeeck; Honghua Zheng; Xia Li; Rosa Rademakers; Silvia S Kang; Huaxi Xu; Steven Younkin; Pritam Das; John D Fryer; Guojun Bu
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

5.  The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.

Authors:  Charles C Bailey; Lindsey B DeVaux; Michael Farzan
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

Review 6.  Regulation of microglial survival and proliferation in health and diseases.

Authors:  Tyler K Ulland; Yaming Wang; Marco Colonna
Journal:  Semin Immunol       Date:  2016-03-28       Impact factor: 11.130

7.  Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.

Authors:  Claudia Olive; Laura Ibanez; Fabiana H Geraldo Farias; Fengxian Wang; John P Budde; Joanne B Norton; Jen Gentsch; John C Morris; Zeran Li; Umber Dube; Jorge Del-Aguila; Kristy Bergmann; Joseph Bradley; Bruno A Benitez; Oscar Harari; Anne Fagan; Beau Ances; Carlos Cruchaga; Maria Victoria Fernandez
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.

Authors:  Mahdi Ghani; Christine Sato; Erfan Ghani Kakhki; J Raphael Gibbs; Bryan Traynor; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2016-03-21       Impact factor: 4.673

9.  Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese population.

Authors:  Zhiming Li; Li Zhong; Long Gu; Wenqing Huang; Xinzhen Shi; Xilin Zhang; Xingkai An; Qing Lin; Chi-Meng Tzeng
Journal:  BMJ Open       Date:  2016-01-12       Impact factor: 2.692

Review 10.  TREM2 in CNS homeostasis and neurodegenerative disease.

Authors:  Meghan M Painter; Yuka Atagi; Chia-Chen Liu; Rosa Rademakers; Huaxi Xu; John D Fryer; Guojun Bu
Journal:  Mol Neurodegener       Date:  2015-09-04       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.